PTC Therapeutics Q1 EPS $(0.03) Beats $(0.48) Estimate, Sales $272.551M Beat $218.805M Estimate
PTC Therapeutics (NASDAQ:PTCT) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.48) by 93.75 percent. This is a 100.3 percent decrease over earnings of $10.04 per share from
